Table 1:

Demographics and clinical characteristics of all 243 patients treated with FAS

Characteristic	N=243 N (%)
Age, years
Median	56
Interquartile range	47–63
Sex
Male	137 (56)
Female	106 (44)
Tumor type
Nonfunctioning	218 (90)
Functioning	25 (10)
Genetic syndrome
Sporadic	231 (95)
Multiple endocrine neoplasia type 1	12 (5)
Tumor status
Locally advanced	20 (8)
Metastatic	223 (92)
FAS line of therapy
First	208 (86)
Second or greater	35 (14)
Resection of the primary tumor
No	191 (79)
Yes	52 (21)
First post-FAS scan result, % (95% CI)
Complete or partial response	41 % (95% CI: 36–48%)